Allon Therapeutics Inc NPCUF

Healthcare Biotechnology

Allon Therapeutics, Inc. is a Canada-based Company, which develops treatments for neurodegenerative diseases. The Company is engaged in pre-clinical and clinical development of proprietary neuroprotective compounds which may be applied for the potential treatment of Alzheimer's Disease, Parkinson's Disease, senile dementia, glaucoma, traumatic head injury, neuronal damage due to stroke and other conditions involving neurodegeneration. The Company's drug, davunetide, is proceeding in a pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP), under a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA).

GREY:NPCUF - Post by User

Allon Therapeutics Inc > NAPEC COULD BE AN INTERESTING TAKEOVER

<< Previous

Bullboard Posts

Next >>

Post by modulexon Jul 21, 2016 8:05am

170 Views

Post# 25071420

NAPEC COULD BE AN INTERESTING TAKEOVER

NAPEC STOCK HAS LONG BEEN IN THE DUMPS, MARKET-WISE. IT PUTTED A NEW MANAGEMENT IN PLACE AND THE SHARE PRICE IS SLOWLY GETTING BETTER. GIVEN THAT THERE WERE ATTEMPTS TAKEOVER BIDS MADE APPARENTLY BY USA QANTAS SERVICES A FEW YEARS AGO AT APPROXIMATELY $2.15/SHARE, WHICH INFORMATION WAS NOT DISCLOSED BY THE FORMER CEO ANDRE LARAMEE, NAPEC COULD AGAIN GET THE ATTENTION OF A USA OR OTHER COMPETITOR. THE STOCK COULD REACH EASILY $5.00. HOLD ON TO YOUR SHARES. DONT SELL AND YOU WILL BE GLADLY REWARDED SOMEDAY.

<< Previous

Bullboard Posts

Next >>

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle